PT1057828E - Suspensoes de trovafloxacina para administracao oral - Google Patents
Suspensoes de trovafloxacina para administracao oralInfo
- Publication number
- PT1057828E PT1057828E PT00304550T PT00304550T PT1057828E PT 1057828 E PT1057828 E PT 1057828E PT 00304550 T PT00304550 T PT 00304550T PT 00304550 T PT00304550 T PT 00304550T PT 1057828 E PT1057828 E PT 1057828E
- Authority
- PT
- Portugal
- Prior art keywords
- oral administration
- crystals
- trovafloxacine
- suspension
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13746399P | 1999-06-04 | 1999-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1057828E true PT1057828E (pt) | 2003-07-31 |
Family
ID=22477550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00304550T PT1057828E (pt) | 1999-06-04 | 2000-05-30 | Suspensoes de trovafloxacina para administracao oral |
Country Status (10)
Country | Link |
---|---|
US (1) | US6239141B1 (pt) |
EP (1) | EP1057828B1 (pt) |
JP (1) | JP3465820B2 (pt) |
AT (1) | ATE234835T1 (pt) |
BR (1) | BR0002577A (pt) |
CA (1) | CA2311112A1 (pt) |
DE (1) | DE60001687T2 (pt) |
DK (1) | DK1057828T3 (pt) |
ES (1) | ES2194677T3 (pt) |
PT (1) | PT1057828E (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL148820A0 (en) * | 1999-10-08 | 2002-09-12 | Smithkline Beecham Corp | Fab i inhibitors |
BR0207930A (pt) * | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas lìquidas com sabor mascarado |
AU2002367773A1 (en) * | 2001-04-06 | 2003-11-03 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
US20030068829A1 (en) * | 2001-06-25 | 2003-04-10 | Symyx Technologies, Inc. | High throughput crystallographic screening of materials |
CA2453182A1 (en) * | 2001-07-10 | 2003-01-23 | Meredith L. Greene | Crystalline thiazine oxazolidinones |
EP1419151B1 (en) | 2001-08-15 | 2014-02-26 | Pharmacia & Upjohn Company LLC | Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl] -5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl] -2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
AU2003220058B2 (en) * | 2002-03-12 | 2008-05-01 | Toyama Chemical Company Limited | Palatable oral suspension and method |
WO2003093322A2 (en) * | 2002-04-30 | 2003-11-13 | The Population Council, Inc. | Carrageenan based antimicrobial compositions |
US8367098B2 (en) * | 2002-04-30 | 2013-02-05 | The Population Council, Inc. | Unique combinations of antimicrobial compositions |
US7790709B2 (en) | 2002-12-06 | 2010-09-07 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
WO2004082586A2 (en) | 2003-03-17 | 2004-09-30 | Affinium Pharmaceuticals, Inc. | Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
JP2006528182A (ja) * | 2003-07-18 | 2006-12-14 | サンタラス インコーポレイティッド | 薬学的製剤および酸に起因する消化器疾患の治療法 |
PT1828167E (pt) * | 2004-06-04 | 2014-10-08 | Debiopharm Int Sa | Derivados de acrilamida como agentes antibióticos |
WO2007067416A2 (en) * | 2005-12-05 | 2007-06-14 | Affinium Pharmaceuticals, Inc. | Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
EP2687533B1 (en) | 2006-07-20 | 2017-07-19 | Debiopharm International SA | Acrylamide derivatives as FAB I inhibitors |
EP2125802A4 (en) | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
RS58898B1 (sr) | 2012-06-19 | 2019-08-30 | Debiopharm Int Sa | Prolek derivati (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamida |
LT3419628T (lt) | 2016-02-26 | 2021-01-25 | Debiopharm International Sa | Medikamentas diabetinėms pėdų infekcijoms gydyti |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164402A (en) | 1989-08-16 | 1992-11-17 | Pfizer Inc | Azabicyclo quinolone and naphthyridinone carboxylic acids |
US5266559A (en) | 1989-10-27 | 1993-11-30 | Firmenich S.A. | Use of unsaturated macrocyclic lactones as perfuming ingredients |
US5391763A (en) | 1990-07-11 | 1995-02-21 | Pfizer Inc. | 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids |
TW271400B (pt) | 1992-07-30 | 1996-03-01 | Pfizer | |
US5763454A (en) | 1995-06-06 | 1998-06-09 | Pfizer, Inc. | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
NZ310542A (en) * | 1995-08-29 | 1999-09-29 | Pfizer | Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin selected from its polymorph, its pseodomorphs and the monohydrate, preparation and pharmaceutical compositions thereof |
TR199800339T1 (xx) * | 1995-08-29 | 1998-06-22 | Pfizer Inc. | Trovafloksasinin melez iyonik bi�imleri. |
US6114531A (en) * | 1998-07-28 | 2000-09-05 | Pfizer Inc. | Process for preparing quinolone and naphthyridone carboxylic acids |
-
2000
- 2000-05-05 US US09/565,420 patent/US6239141B1/en not_active Expired - Fee Related
- 2000-05-16 JP JP2000142971A patent/JP3465820B2/ja not_active Expired - Fee Related
- 2000-05-30 EP EP00304550A patent/EP1057828B1/en not_active Expired - Lifetime
- 2000-05-30 PT PT00304550T patent/PT1057828E/pt unknown
- 2000-05-30 DE DE60001687T patent/DE60001687T2/de not_active Expired - Fee Related
- 2000-05-30 ES ES00304550T patent/ES2194677T3/es not_active Expired - Lifetime
- 2000-05-30 AT AT00304550T patent/ATE234835T1/de not_active IP Right Cessation
- 2000-05-30 DK DK00304550T patent/DK1057828T3/da active
- 2000-06-02 CA CA002311112A patent/CA2311112A1/en not_active Abandoned
- 2000-06-05 BR BR0002577-1A patent/BR0002577A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR0002577A (pt) | 2001-01-02 |
EP1057828A3 (en) | 2001-05-16 |
DE60001687D1 (de) | 2003-04-24 |
JP3465820B2 (ja) | 2003-11-10 |
CA2311112A1 (en) | 2000-12-04 |
DE60001687T2 (de) | 2003-12-18 |
DK1057828T3 (da) | 2003-07-14 |
EP1057828B1 (en) | 2003-03-19 |
US6239141B1 (en) | 2001-05-29 |
EP1057828A2 (en) | 2000-12-06 |
ES2194677T3 (es) | 2003-12-01 |
JP2000344770A (ja) | 2000-12-12 |
ATE234835T1 (de) | 2003-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1057828E (pt) | Suspensoes de trovafloxacina para administracao oral | |
IL165715A0 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
WO2003064431A3 (en) | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | |
YU62999A (sh) | C-4"-supstituisani derivati makrolida | |
BG101118A (en) | Therapeutical compounds | |
TWI232219B (en) | Compounds containing cyclohexane group, process for preparing them and pharmaceutical composition containing them | |
EP1024145A3 (en) | Novel azalides and methods of making same | |
MA25009A1 (fr) | Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes | |
CY1111693T1 (el) | Αντιιικοι παραγοντες | |
TR200100377T2 (tr) | Aß Protein üretimi inhibitörleri olarak sukinoilamino laktamlar. | |
MXPA02011303A (es) | Nueva composicion farmaceutica. | |
YU41500A (sh) | Novi makrolidi | |
EE200200208A (et) | Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid | |
TR200102128T2 (tr) | Ketolid antibiyotikler | |
PA8486401A1 (es) | Antibioticos cetolidos carbamato y carbazato | |
AP2001002142A0 (en) | 13-membered azalides and their use as antibiotic agents. | |
HUP0004282A2 (hu) | 2-Halogén-6-0-szubsztituált ketolidszármazékok | |
ATE268337T1 (de) | C11-carbamate von antibakteriellen makroliden | |
DE60208404D1 (de) | Kreuzverquerte glycopeptid-cephalosporin-antibiotika | |
UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. | |
NO20042711L (no) | Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum | |
CY1106552T1 (el) | Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς | |
ITMI20021405A0 (it) | Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio | |
BR9902049A (pt) | Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina. |